Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStopping Mounjaro is a decision many people reach for different reasons — side effects, a planned pregnancy, surgery, or simply feeling ready to try without it. As a prescription-only medicine, how and when you come off tirzepatide should always be guided by the clinician who prescribed it, never decided unilaterally. Your prescriber can review your current dose, your weight trajectory, and any conditions being managed alongside treatment, before agreeing a plan that makes sense for your situation. If you're working with an online pharmacy, that review is part of what you're paying for.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the scene: your Mounjaro pen is sitting in the fridge door, you've been on 5mg for two months, and you've made up your mind that you want to come off it. The first thing to know is that there is no medically mandated taper for tirzepatide the way there is for, say, long-term steroids. The NHS medicines page for tirzepatide confirms it is a once-weekly injection with a titration schedule managed by your prescriber, and your prescriber is equally the right person to manage coming off it.
That said, stopping abruptly after a higher maintenance dose may mean appetite returns more quickly than a gradual step-down. Some clinicians choose to reduce the dose over several weeks before stopping entirely; others agree an immediate stop is appropriate. Neither is universally right. What matters is that the decision fits your circumstances: your current dose, how long you've been on treatment, your weight history, and whether any of the conditions tirzepatide was helping to manage (blood pressure, blood sugar, cholesterol) need closer attention once the medicine is withdrawn.
If you're considering stopping because of a specific side effect rather than a planned transition, reaching out to our aftercare team before stopping altogether is worth doing. Often a dose adjustment or a brief pause resolves the problem without ending treatment entirely.
Mounjaro is a Prescription-Only Medicine. That status doesn't just govern getting it, it governs changing or stopping it too. A prescriber must be in the loop. If you sourced your treatment through a regulated online pharmacy, you are entitled to a clinical review before any change; reputable services build that in as standard.
How do you know your pharmacy is legitimate? The simplest check is the GPhC register, where you can verify any UK pharmacy by its premises registration number. Pharmacies operating legally will display this number readily. If yours doesn't, or if you originally obtained tirzepatide from a seller who supplied it without a prescription, that's worth flagging: the MHRA has warned publicly about counterfeit weight-loss pens sold through social media and unlicensed websites, with some containing harmful substances. You can report a suspect seller at the MHRA's Yellow Card site.
At nume, stopping, pausing, or changing your treatment is handled the same way as starting it, a prescriber reviews your case and responds the same day. You don't need to navigate an automated system or wait for a scheduled callback. The clinical team handles these conversations as a routine part of aftercare.
This is the question our prescribers hear most often from people weighing up whether to stop. The honest answer is that tirzepatide suppresses appetite and slows gastric emptying while you're taking it; when you stop, those effects gradually reverse over the weeks following your last dose. Clinical trial data and post-trial observation both suggest that some weight regain is common after stopping GLP-1 and dual-agonist medicines, though the degree varies considerably between individuals. NICE's appraisal of tirzepatide (TA1026) notes that the decision to continue or stop should be reviewed at six months if weight loss has been insufficient, which reflects the same thinking applied in reverse: stopping is a medical review, not just an administrative one.
Lifestyle habits built during treatment (eating patterns, activity levels, the cues you've developed around hunger) tend to be the strongest buffer against regain. Your prescriber may want to discuss whether other weight management options make sense as a bridge, or whether a planned pause with a route back into treatment is more appropriate than a permanent stop.
If stopping is linked to a specific life event (surgery, pregnancy planning, or a period off injectable medicines) the timeline matters. Tirzepatide's prescribing information gives guidance on washout periods for conception planning; your prescriber will apply this to your specific situation rather than a one-size answer.
If your treatment is currently through nume, the simplest step is to contact our team directly via the support page, aftercare is available seven days a week and is part of what your prescription includes. If you're transferring from another provider, or if you're exploring treatment for the first time and want to understand all your options for getting Mounjaro before committing, a free consultation is the starting point. A named prescriber reviews your answers the same day and will be honest if treatment isn't the right next step, or if stopping is.
People who want to get back on Mounjaro after a break often find the process for restarting straightforward through a regulated online pharmacy; evidence of your previous treatment and current weight is part of the clinical review. Those exploring the NHS route for tirzepatide should know that eligibility thresholds are strict and phased; if you've decided you're ready to buy Mounjaro now through a regulated private pharmacy, that is often the practical alternative for people outside the current NHS criteria. If you're unsure where to begin, a good starting point is reading how the Mounjaro jab is prescribed and administered, which covers what to expect from the process end to end.
Whatever your reason for stepping off, it deserves the same clinical attention as stepping on.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.